Anti-SERINC2 antibody (ab134312)
Key features and details
- Rabbit polyclonal to SERINC2
- Suitable for: WB, IHC-P, ICC/IF
- Reacts with: Mouse, Human
- Isotype: IgG
Overview
-
Product name
Anti-SERINC2 antibody -
Description
Rabbit polyclonal to SERINC2 -
Host species
Rabbit -
Tested applications
Suitable for: WB, IHC-P, ICC/IFmore details -
Species reactivity
Reacts with: Mouse, Human
Predicted to work with: Rat
-
Immunogen
Synthetic peptide derived from the C terminus of Human SERINC2.
-
General notes
Reproducibility is key to advancing scientific discovery and accelerating scientists’ next breakthrough.
Abcam is leading the way with our range of recombinant antibodies, knockout-validated antibodies and knockout cell lines, all of which support improved reproducibility.
We are also planning to innovate the way in which we present recommended applications and species on our product datasheets, so that only applications & species that have been tested in our own labs, our suppliers or by selected trusted collaborators are covered by our Abpromise™ guarantee.
In preparation for this, we have started to update the applications & species that this product is Abpromise guaranteed for.
We are also updating the applications & species that this product has been “predicted to work with,” however this information is not covered by our Abpromise guarantee.
Applications & species from publications and Abreviews that have not been tested in our own labs or in those of our suppliers are not covered by the Abpromise guarantee.
Please check that this product meets your needs before purchasing. If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, as well as customer reviews and Q&As.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. -
Storage buffer
pH: 7.40
Preservative: 0.02% Sodium azide
Constituents: 49% PBS, 0.88% Sodium chloride, 50% Glycerol
PBS without Mg2+ and Ca2+. -
Concentration information loading... -
Purity
Immunogen affinity purified -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Associated products
-
Compatible Secondaries
-
Isotype control
-
Positive Controls
Applications
Our Abpromise guarantee covers the use of ab134312 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| WB | 1/500 - 1/1000. Predicted molecular weight: 51 kDa. | |
| IHC-P | Use a concentration of 5 µg/ml. | |
| ICC/IF | 1/100 - 1/500. |
Target
- Information by UniProt
-
Database links
- Entrez Gene: 347735 Human
- Entrez Gene: 230779 Mouse
- Entrez Gene: 313057 Rat
- Omim: 614549 Human
- SwissProt: Q96SA4 Human
- SwissProt: Q8K0E7 Mouse
- Unigene: 270655 Human
- Unigene: 45132 Mouse
see all -
Alternative names
- AW121759 antibody
- FKSG84 antibody
- MGC116219 antibody
see all
Images
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SERINC2 antibody (ab134312)Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human skin (epidermis) tissue labelling SERINC2 with ab134312 at 5 µg/ml, using a biotinylated goat anti-rabbit IgG secondary antibody, alkaline phosphatase-streptavidin and chromogen.
-
Western blot - Anti-SERINC2 antibody (ab134312)All lanes : Anti-SERINC2 antibody (ab134312) at 1/500 dilution
Lane 1 : HeLa cell extracts
Lane 2 : HeLa cell extracts with immunising peptide
Predicted band size: 51 kDa -
Immunocytochemistry/ Immunofluorescence - Anti-SERINC2 antibody (ab134312)Immunofluorescent analysis of NIH-3T3 cells labelling SERINC2 with ab134312 at 1/100 dilution. Right image is treated with the immunising peptide.
Protocols
Datasheets and documents
References (2)
ab134312 has been referenced in 2 publications.
- Zeng Y et al. SERINC2-knockdown inhibits proliferation, migration and invasion in lung adenocarcinoma. Oncol Lett 16:5916-5922 (2018). PubMed: 30405754
- Mather Q et al. A novel protein expression signature differentiates benign lipomas from well-differentiated liposarcomas. Mol Clin Oncol 7:315-321 (2017). PubMed: 28781809
